---
title: "Collaboration aims to develop a bespoke cell phenotyping assay for human blood"
date: "2024-01-23T10:32:35.000Z"
publishedDate: "23 janvier 2024"
summary: "PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease (CAD), has announced a collaboration to develop a cell phenotyping assay to detect cell subpopulations in human blood. Once validated, the bespoke assay will be available as a service in the Flow Cytometry Facility at the Babraham Institute (Cambridge, UK)."
importance: ""
sourceUrl: "https://cardiovascularnews.com/collaboration-cell-phenotyping-assay/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-01-23-collaboration-aims-to-develop-a-bespoke-cell-phenotyping-assay-for-human-blood"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/01/Flow-Cytometry-and-PlaqueTec.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/collaboration-cell-phenotyping-assay/"
---

![Collaboration aims to develop a bespoke cell phenotyping assay for human blood](https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/01/Flow-Cytometry-and-PlaqueTec.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/collaboration-cell-phenotyping-assay/*

## L’essentiel

PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease (CAD), has announced a collaboration to develop a cell phenotyping assay to detect cell subpopulations in human blood. Once validated, the bespoke assay will be available as a service in the Flow Cytometry Facility at the Babraham Institute (Cambridge, UK).

## Lien source

https://cardiovascularnews.com/collaboration-cell-phenotyping-assay/
